UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

The lancet oncology, 2021-11, Vol.22 (11), p.1560-1572

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysis

Scientific reports, 2024-03, Vol.14 (1), p.5406-5406

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma

Liver international, 2021-06, Vol.41 (6), p.1398-1408

2021

Link zum Volltext

Verfügbarkeit prüfen

CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy

European radiology, 2021-02, Vol.31 (2), p.813-823

2021

Link zum Volltext

Verfügbarkeit prüfen

Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models

Drug delivery, 2022-12, Vol.29 (1), p.2897-2911

2022

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic body radiation therapy for locally advanced pancreatic cancer

PloS one, 2019-04, Vol.14 (4), p.e0214970-e0214970

2019

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis

British journal of cancer, 2020-08, Vol.123 (3), p.362-368

2020

Link zum Volltext

Verfügbarkeit prüfen

Prediction of margin‐negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT‐determined resectability

Journal of hepato-biliary-pancreatic sciences, 2022-09, Vol.29 (9), p.1025-1034

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world data analysis of patients with cancer of unknown primary

Scientific reports, 2021-11, Vol.11 (1), p.23074-23074, Article 23074

2021

Link zum Volltext

Verfügbarkeit prüfen

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis

Investigational new drugs, 2018-08, Vol.36 (4), p.732-741

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy for recurrent extrahepatic bile duct cancer

PloS one, 2021-06, Vol.16 (6), p.e0253285-e0253285

2021

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

Scientific reports, 2021-03, Vol.11 (1), p.7118-9, Article 7118

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Cancers, 2022-01, Vol.14 (3), p.559

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer

Breast cancer research and treatment, 2018, Vol.167 (2), p.469-478

2018

Link zum Volltext

Verfügbarkeit prüfen

siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

Cells (Basel, Switzerland), 2021-10, Vol.10 (10), p.2734

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis

Transfusion (Philadelphia, Pa.), 2019-05, Vol.59 (5), p.1781-1788

2019

Link zum Volltext

Verfügbarkeit prüfen

Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea

BMC cancer, 2018-11, Vol.18 (1), p.1081-1081, Article 1081

2018

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment

Medical oncology (Northwood, London, England), 2018-05, Vol.35 (5), p.65-6, Article 65

2018

Link zum Volltext

Verfügbarkeit prüfen

L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells

Free radical biology & medicine, 2016-06, Vol.95, p.200-208

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic criteria for autoimmune chronic pancreatitis revisited

World journal of gastroenterology : WJG, 2006-04, Vol.12 (16), p.2487

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211003053-17588359211003053

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores

Investigational new drugs, 2019-06, Vol.37 (3), p.584-590

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(275)

Publikationsform

Artikel
(290)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(163)
Humans
(139)
Oncology
(113)
Male
(104)
Female
(95)
Middle Aged
(85)
Aged
(83)
Adult
(82)
Chemotherapy
(56)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(41)
Medicine
(41)
Pharmacology & Pharmacy
(39)
Medicine & Public Health
(37)
Treatment Outcome
(37)
Tumors
(37)
Metastasis
(35)
Patients
(34)
Retrospective Studies
(33)
Survival
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysis

Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma

CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy

Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models

Stereotactic body radiation therapy for locally advanced pancreatic cancer

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis

Prediction of margin‐negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT‐determined resectability

Real-world data analysis of patients with cancer of unknown primary

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis

Radiation therapy for recurrent extrahepatic bile duct cancer

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer

siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis

Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis

Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea

Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment

L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells

Diagnostic criteria for autoimmune chronic pancreatitis revisited

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores

Suchergebnisse filtern